Organization · Venture Capital
TWITI Investments
TWITI Investments is a private investment fund focused on the biotech and medtech sectors, primarily investing in early-stage companies in Central and Eastern Europe. The firm provides capital, counseling, and networking to support innovative startups.
Overview
What TWITI Investments does
What TWITI Investments is
TWITI Investments is a private investment fund focused on the biotech and medtech sectors, primarily investing in early-stage companies in Central and Eastern Europe. The firm provides capital, counseling, and networking to support innovative startups.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2011
- Approximate age
- About 15 years
- Structured capabilities
- Funder
- Last reviewed
- March 30, 2026
Official channels
Find TWITI Investments elsewhere
Open the official website or a supported primary organization account.
Capability profile
TWITI Investments as a funder
Investment thesis
TWITI Investments focuses on innovative biotech and medtech startups, providing financing, counseling, and networking to support breakthrough technologies in the healthcare sector.
Focus narrative
TWITI Investments primarily targets biotech and medtech startups, focusing on teams of scientists and managers with an entrepreneurial spirit. The firm invests in projects that require time to achieve specific milestones and emphasizes breakthrough technologies that can significantly change current therapeutic approaches.
Value beyond capital
TWITI Investments adds value to its portfolio companies through a combination of capital, strategic counseling, and access to a robust network of pharma companies, research institutions, regulatory experts, and follow-on investors. This 'smart money' approach enhances the growth potential of its investments.
Focus and fit
- Stages
- Seed · Series A
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 8
Portfolio context
Notable portfolio companies include: Mabion: A biotech company in Central Europe focused on developing and manufacturing drugs based on monoclonal antibodies technology. Lipid Systems: Specializes in nanotechnology and has developed a targeted delivery system using liposomal encapsulation technology. QVITI: A med-tech company providing innovative solutions in neuroscience, neurostimulation, and neurotherapy. Genexo: A pharmaceutical company focused on private label products and self-testing medical devices, particularly for diabetes patients. Cellis: An innovative startup utilizing human immune cells for drug delivery to solid tumors and inflammatory sites. Urteste: A public company developing a method for early cancer detection from a single urine sample. Captor Therapeutics: A biopharmaceutical company developing targeted protein degradation drugs for cancer and autoimmune diseases. Uvera: Focused on developing protective ingredients against UV radiation. Human Biome Institute: Specializes in microbiome therapy for patients with intestinal dysbiosis.
Common questions
What to know about TWITI Investments
Upseed classifies TWITI Investments under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 30, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.